Abeona Therapeutics Current Ratio 2010-2022 | ABEO

Abeona Therapeutics current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Abeona Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-09-30 $0.03B $0.01B 2.02
2022-06-30 $0.03B $0.01B 2.21
2022-03-31 $0.04B $0.01B 3.18
2021-12-31 $0.06B $0.02B 3.39
2021-09-30 $0.07B $0.03B 2.57
2021-06-30 $0.08B $0.04B 1.88
2021-03-31 $0.09B $0.04B 2.17
2020-12-31 $0.10B $0.04B 2.33
2020-09-30 $0.11B $0.04B 2.70
2020-06-30 $0.11B $0.04B 2.90
2020-03-31 $0.12B $0.04B 3.24
2019-12-31 $0.13B $0.04B 3.42
2019-09-30 $0.05B $0.02B 2.45
2019-06-30 $0.07B $0.03B 2.54
2019-03-31 $0.07B $0.02B 3.35
2018-12-31 $0.09B $0.02B 4.37
2018-09-30 $0.12B $0.01B 11.09
2018-06-30 $0.12B $0.01B 21.07
2018-03-31 $0.13B $0.01B 20.79
2017-12-31 $0.14B $0.01B 25.07
2017-09-30 $0.06B $0.00B 22.13
2017-06-30 $0.06B $0.00B 14.05
2017-03-31 $0.06B $0.01B 10.52
2016-12-31 $0.07B $0.01B 8.37
2016-09-30 $0.03B $0.01B 4.90
2016-06-30 $0.04B $0.01B 3.98
2016-03-31 $0.04B $0.01B 4.95
2015-12-31 $0.04B $0.00B 27.47
2015-09-30 $0.04B $0.00B 27.83
2015-06-30 $0.03B $0.00B 16.13
2015-03-31 $0.01B $0.00B 6.61
2014-12-31 $0.01B $0.00B 3.99
2014-09-30 $0.00B $0.01B 0.02
2014-06-30 $0.00B $0.01B 0.02
2014-03-31 $0.00B $0.01B 0.04
2013-12-31 $0.00B $0.01B 0.06
2013-09-30 $0.00B $0.01B 0.13
2013-06-30 $0.00B $0.01B 0.30
2013-03-31 $0.00B $0.01B 0.22
2012-12-31 $0.00B $0.01B 0.25
2012-09-30 $0.00B $0.01B 0.10
2012-06-30 $0.00B $0.01B 0.15
2012-03-31 $0.00B $0.01B 0.22
2011-12-31 $0.00B $0.01B 0.27
2011-09-30 $0.00B $0.01B 0.12
2011-06-30 $0.00B $0.01B 0.35
2011-03-31 $0.01B $0.02B 0.42
2010-12-31 $0.01B $0.01B 0.57
2010-09-30 $0.00B $0.01B 0.11
2010-06-30 $0.00B $0.01B 0.35
2010-03-31 $0.00B $0.01B 0.51
2009-12-31 $0.00B $0.01B 0.08
2009-09-30 $0.00B $0.01B 0.22
2009-06-30 $0.00B $0.01B 0.18
2009-03-31 $0.00B $0.01B 0.38
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.047B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00